Pancreatic Neoplasms: all 3,310 studies

Page 12 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.

• Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer PatientsCompletedNCT02245217Not applicableResults posted
• Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic CancerCompletedNCT02243358Phase 2Results posted
• Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic CancerTerminatedNCT02243007Phase 2Results posted
• Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic CancerTerminatedNCT02241551Phase 2Results posted
• Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical ResectionCompletedNCT02241187Not applicableResults posted
• Pre-operative Biliary SEMS RCT During Neoadjuvant TherapyCompletedNCT02238847Not applicableResults posted
• A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic CancerCompletedNCT02237157Phase 1Results posted
• A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic CancerCompletedNCT02210559Phase 1/2Results posted
• Whipple Procedure: Standard of Care vs. ThunderbeatTerminatedNCT02204124Not applicableResults posted
• Cancer Associated Thrombosis and Isoquercetin (CATIQ)CompletedNCT02195232Phase 2/3Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor AZD1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT02194829Phase 1/2Results posted
• Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based ChemotherapyCompletedNCT02184195Phase 3Results posted
• Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro-core® NeedleCompletedNCT02181140Not applicableResults posted
• Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic CancerCompletedNCT02178436Phase 1/2Results posted
• αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface MalignanciesCompletedNCT02151448Phase 1/2Results posted
• Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic CancerCompletedNCT02128100Phase 2Results posted
• A Study of Ruxolitinib in Pancreatic Cancer PatientsTerminatedNCT02119663Phase 3Results posted
• Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)TerminatedNCT02117479Phase 3Results posted
• Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxelCompletedNCT02106884Phase 2Results posted
• A Study of Regorafenib in Advanced Pancreatic Cancer PatientsCompletedNCT02080260Phase 2Results posted
• BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group TrialCompletedNCT02080221Phase 2Results posted
• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerCompletedNCT02077881Phase 1/2Results posted
• Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerTerminatedNCT02047500Phase 1Results posted
• Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic CancerCompletedNCT02047474Phase 2Results posted
• BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group TrialCompletedNCT02022033Phase 2Results posted
• Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic CancerCompletedNCT02017015Phase 2Results posted
• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsCompletedNCT02009449Phase 1Results posted
• Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer SettingCompletedNCT02004262Phase 2Results posted
• A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the PancreasCompletedNCT01985958Not applicableResults posted
• Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out HydroxychloroquineCompletedNCT01978184Phase 2Results posted
• MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic CancerCompletedNCT01972919Phase 2Results posted
• Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)CompletedNCT01964430Phase 3Results posted
• Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic CancerCompletedNCT01959672Phase 2Results posted
• Gemcitabine Pharmacokinetics After Preoperative Chemoradiation TherapyTerminatedNCT01938716Not applicableResults posted
• Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic CancerCompletedNCT01926197Phase 3Results posted
• High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryTerminatedNCT01921751Phase 2Results posted
• Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic CancerCompletedNCT01905150Phase 2Results posted
• Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic CancerTerminatedNCT01897454Phase 2Results posted
• FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic CancerCompletedNCT01896869Phase 2Results posted
• Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDACompletedNCT01893801Phase 1/2Results posted
• Maintenance Dovitinib for Colorectal and Pancreas CancerTerminatedNCT01888965Phase 2Results posted
• Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic CancerTerminatedNCT01851174Phase 2Results posted
• Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)CompletedNCT01845805Phase 2Results posted
• Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic CancerCompletedNCT01844817Phase 2Results posted
• PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerCompletedNCT01839487Phase 2Results posted
• A Phase II Study of Pioglitazone for Patients With Cancer of the PancreasCompletedNCT01838317Phase 2Results posted
• QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic CancerTerminatedNCT01834235Phase 1/2Results posted
• A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic CancerCompletedNCT01833546Phase 1Results posted
• Radiation w/FOLFIRINOX-Losartan for Pancreatic CancerCompletedNCT01821729Phase 2Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine TumorsTerminatedNCT01784861Phase 1/2Results posted
• An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01782690Results posted
• Palliative Stereotactic Radiation for Pancreatic or Periampullary AdenocarcinomaCompletedNCT01781728Phase 2Results posted
• Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary CancerCompletedNCT01774019Not applicableResults posted
• MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentCompletedNCT01770353Phase 1Results posted
• GTX-RT in Borderline Resectable Pancreatic CancerTerminatedNCT01754623Phase 2Results posted
• BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group StudyCompletedNCT01744353Phase 1Results posted
• Minocycline Study in Pancreatic Cancer PatientsCompletedNCT01693523Phase 2Results posted
• FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic CancerTerminatedNCT01688336Phase 2Results posted
• Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic CancerTerminatedNCT01683422Not applicableResults posted
• Trial Comparing 19 and 25-gauge EUS-FNA NeedlesCompletedNCT01677312Not applicableResults posted
• Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic CancerCompletedNCT01666730Phase 2Results posted
• A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01663272Phase 1Results posted
• A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in PatientsCompletedNCT01661088Phase 2Results posted
• Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyCompletedNCT01658943Phase 2Results posted
• Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic AdenocarcinomaCompletedNCT01652976Phase 2Results posted
• A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic CancerCompletedNCT01647828Phase 1/2Results posted
• A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic CancerTerminatedNCT01632306Phase 1/2Results posted
• Comparison of a Novel 22-gauge Core Biopsy NeedleCompletedNCT01598194Not applicableResults posted
• Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the PancreasCompletedNCT01595321Phase 2Results posted
• FOLFIRINOX + RT for Pancreatic CancerCompletedNCT01591733Phase 2Results posted
• Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNCT01585805Phase 2Results posted
• CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic CancerTerminatedNCT01583686Phase 1/2Results posted
• Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the PancreasCompletedNCT01560949Phase 2Results posted
• Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic CaTerminatedNCT01555489Phase 2Results posted
• Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic CancerCompletedNCT01534637Phase 2Results posted
• Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsCompletedNCT01525082Phase 2Results posted
• Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic CancerCompletedNCT01523808Phase 1Results posted
• Study of Modified FOLFIRINOX in Advanced Pancreatic CancerCompletedNCT01523457Phase 2Results posted
• Clinical Trial of High-dose Vitamin C for Advanced Pancreatic CancerTerminatedNCT01515046Phase 2Results posted
• A Phase 2 Study of LY2495655 in Participants With Pancreatic CancerCompletedNCT01505530Phase 2Results posted
• Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic CancerCompletedNCT01494506Phase 3Results posted
• Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic CancerCompletedNCT01494155Phase 2Results posted
• ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic CancerCompletedNCT01489865Phase 1/2Results posted
• Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01473940Phase 1Results posted
• Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic CancerCompletedNCT01459614Phase 2Results posted
• Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic CancerCompletedNCT01453153Phase 1/2Results posted
• Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal CancersTerminatedNCT01445327Results posted
• Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaCompletedNCT01444456Results posted
• Pancreas Resection With and Without DrainsCompletedNCT01441492Not applicableResults posted
• Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or PancreasCompletedNCT01438476Phase 3Results posted
• Study of Ruxolitinib in Pancreatic Cancer PatientsCompletedNCT01423604Phase 2Results posted
• Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic CancerCompletedNCT01417000Phase 2Results posted
• Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic CancerCompletedNCT01395017Phase 2Results posted
• 22G FNA Needle vs. 22G ProCore NeedleCompletedNCT01394159Not applicableResults posted
• A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic CancerCompletedNCT01373164Phase 1/2Results posted
• SS1P and Pentostatin Plus Cyclophosphamide for MesotheliomaCompletedNCT01362790Phase 1/2Results posted
• Reinforced Staple Line on Leak Rate in Distal PancreatectomyTerminatedNCT01359410Not applicableResults posted
• Stereotactic Body Radiotherapy for Unresectable Pancreatic CancerCompletedNCT01346410Not applicableResults posted
• Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic CancerCompletedNCT01342354Phase 1/2Results posted

← Pancreatic Neoplasms overview